CN104352801A - 一种治疗疑病症的中药及其制备方法 - Google Patents
一种治疗疑病症的中药及其制备方法 Download PDFInfo
- Publication number
- CN104352801A CN104352801A CN201410576415.3A CN201410576415A CN104352801A CN 104352801 A CN104352801 A CN 104352801A CN 201410576415 A CN201410576415 A CN 201410576415A CN 104352801 A CN104352801 A CN 104352801A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- preparation
- traditional chinese
- gecko
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 201000001916 Hypochondriasis Diseases 0.000 title claims abstract description 11
- 235000000126 Styrax benzoin Nutrition 0.000 claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 238000007789 sealing Methods 0.000 claims abstract description 4
- 210000000582 semen Anatomy 0.000 claims description 14
- 235000015511 Liquidambar orientalis Nutrition 0.000 claims description 13
- 241000736148 Styrax Species 0.000 claims description 13
- 239000004870 Styrax Substances 0.000 claims description 13
- 108010052008 colla corii asini Proteins 0.000 claims description 13
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 18
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 abstract 2
- 238000001035 drying Methods 0.000 abstract 2
- 235000019382 gum benzoic Nutrition 0.000 abstract 2
- 241000758794 Asarum Species 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 240000007049 Juglans regia Species 0.000 abstract 1
- 235000009496 Juglans regia Nutrition 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 241001060310 Styracaceae Species 0.000 abstract 1
- 244000028419 Styrax benzoin Species 0.000 abstract 1
- 235000001361 Styrax officinalis Nutrition 0.000 abstract 1
- 235000008411 Sumatra benzointree Nutrition 0.000 abstract 1
- 229960002130 benzoin Drugs 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 235000020234 walnut Nutrition 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000019901 Anxiety disease Diseases 0.000 description 4
- 230000036506 anxiety Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229940100691 oral capsule Drugs 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- 208000027520 Somatoform disease Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010046543 Urinary incontinence Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 238000002558 medical inspection Methods 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 208000024335 physical disease Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000816 toxic dose Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗疑病症的中药及其制备方法。中药是按以下重量份数比制备而成,苏合香7-15份、苏木6-11份、安息香8-14份、蛤蚧5-10份、阿胶8-15份、核桃9-16份、仙茅6-10份、桑椹子5-10份、石斛7-13份、细辛7-15份。本发明的制备方法是将原料晒干、粉碎成细粉,过200目筛,放在铝制的桶里,密封存放10天,取出,阴干3天,装入胶囊。本发明的药物对治疗疑病症效果很好。本发明所述方法简单、容易操作，药效好，利于推广应用。
Description
技术领域
本发明涉及一种治疗疑病症的中药及其制备方法,具体地说是一种治疗疑病症的中药及其制备方法。
背景技术
疑病症又称疑病性神经症，目前归类为躯体形式障碍中，主要指患者担心或相信患有一种或多种严重躯体疾病，病人诉躯体症状，反复就医，尽管经反复医学检查显示阴性以及医生给予没有相应疾病的医学解释也不能打消病人的顾虑，常伴有焦虑或抑郁。本病多在50岁以前发病，为慢性波动病程，男女均可发生。
目前采用很多方法和药物治疗此病，如使用苯二氮卓类药物等药物，这类药物中,老药疗效较好但副作用大，新药的治疗量和中毒量接近,不好把握,费用也较高。
发明内容
本发明的目的是提供一种疑病症的中药及其制备方法,在祖传秘方的基础上加以改进,充分发挥药物的性能,更好的治疗疑病症。无副作用,制作方法简单。
所述目的是通过如下方案实现的：
一种治疗疑病症的中药,按以下重量份数比制备而成,苏合香7-15份、苏木6-11份、安息香8-14份、蛤蚧5-10份、阿胶8-15份、核桃9-16份、仙茅6-10份、桑椹子5-10份、石斛7-13份、细辛7-15份。
优选方案1:
按以下重量份数比制备而成,苏合香11份、苏木11份、安息香8份、蛤蚧5份、阿胶15份、核桃12份、仙茅10份、桑椹子8份、石斛7份、细辛12份。
优选方案2:
按以下重量份数比制备而成,苏合香7份、苏木8份、安息香14份、蛤蚧8份、阿胶11份、核桃9份、仙茅6份、桑椹子10份、石斛13份、细辛7份。
优选方案3:
按以下重量份数比制备而成,苏合香15份、苏木6份、安息香12份、蛤蚧10份、阿胶8份、核桃16份、仙茅8份、桑椹子5份、石斛10份、细辛15份。
制备方法如下:
将上述原料晒干、粉碎成细粉,过200目筛,放在铝制的桶里,密封存放10天,取出,阴干3天,装入胶囊。
各原料作用:
苏合香:功效与作用：开窍、解郁、化痰，主要为兴奋中枢作用。
苏木:功效与作用：止血行血祛瘀、通络止痛。
安息香:功效与作用：芳香开窍，有兴奋中枢作用，并能行气血和祛痰。
蛤蚧:功效与作用：补肺肾、止喘嗽，有滋补、强壮作用。
阿胶功能:滋阴养血，补肺润燥，止血安胎。主治：虚劳赢瘦、肺痈吐脓、吐血、衄血、便血、经血不调，崩漏带下、胎动不安、阴虚心烦、失眠等症。
核桃:核桃可以改善睡眠质量，常用来治疗神经衰弱、失眠、健忘、多梦等症状。
仙茅:功能：补肾阳，强筋骨，散寒湿。
主治：阳痿精冷，腰膝冷痛，风湿关节炎，慢性肾炎，遗精、小便失禁，心腹冷气等症。
桑椹子:有利尿、镇咳、增强机体抵抗力的作用。
石斛:养胃生津、滋阴清热、补肝益肾。
细辛:功效与作用：散寒、祛痰、止痛。
本发明采用以上配方,在药物间的相互与协同作用下,能促使腠理疏松、经脉调和、气血流畅、镇惊安神、清热除烦。达到彻底治愈的目的。
本发明不反复，疗效快、成本低，治愈率高，无毒副作用。本发明所述方法简单、容易操作，药效好，利于推广应用。
具体实施方式
下面详细阐述本发明优选的实施方式。
将散剂按0.5克装入胶囊,每日服药3次,每次4粒,30天为一个疗程。
实施例1:
一种治疗疑病症的中药,按以下重量份数比制备而成,苏合香7-15份、苏木6-11份、安息香8-14份、蛤蚧5-10份、阿胶8-15份、核桃9-16份、仙茅6-10份、桑椹子5-10份、石斛7-13份、细辛7-15份。制备方法见实施例2。
典型病例：
陈某，女，48岁，经医院检查为疑病症,恶心、反酸、腹泻、心悸、胸痛、呼吸困难。并伴有忧郁、焦虑和惊恐,口服本发明胶囊治疗一个疗程后,症状改善,三个疗程后，症状完全消失，随访一年无复发。
实施例2:
按以下重量份数比制备而成,苏合香11份、苏木11份、安息香8份、蛤蚧5份、阿胶15份、核桃12份、仙茅10份、桑椹子8份、石斛7份、细辛12份。
制备方法:
将上述原料晒干、粉碎成细粉,过200目筛,放在铝制的桶里,密封存放10天,取出,阴干3天,装入胶囊。
典型病例：
谢某，女，36岁，经医院检查为疑病症,头、颈、背、胸经常疼痛,呼吸困难,并伴有忧郁、焦虑和惊恐,口服本发明胶囊治疗一个疗程后,疼痛消失,呼吸顺畅,三个疗程后，症状完全消失，随访一年无复发。
实施例3:
按以下重量份数比制备而成,苏合香7份、苏木8份、安息香14份、蛤蚧8份、阿胶11份、核桃9份、仙茅6份、桑椹子10份、石斛13份、细辛7份。制备方法和实施例2相同。
典型病例：
王某，男，40岁，经医院检查为疑病症,头痛、恶心、反酸、腹泻、呼吸困难。并伴有忧郁、焦虑和惊恐,口服本发明胶囊治疗一个疗程后,症状改善,三个疗程后，症状完全消失，随访一年无复发。
实施例4:
按以下重量份数比制备而成,苏合香15份、苏木6份、安息香12份、蛤蚧10份、阿胶8份、核桃16份、仙茅8份、桑椹子5份、石斛10份、细辛15份。制备方法和实施例2相同。
临床试验疑病症患者25人,治愈20人,好转5人,无效0人。
可见,本发明的药物对治疗疑病症效果很好。
本实施方式只是对本专利的示例性说明而并不限定它的保护范围，本领域人员还可以对其进行局部改变，只要没有超出本专利的精神实质，都视为对本专利的等同替换，都在本专利的保护范围之内。
Claims (5)
1.一种治疗疑病症的中药,其特征在于:按以下重量份数比制备而成,苏合香7-15份、苏木6-11份、安息香8-14份、蛤蚧5-10份、阿胶8-15份、核桃9-16份、仙茅6-10份、桑椹子5-10份、石斛7-13份、细辛7-15份。
2.根据权利要求1所述的一种治疗疑病症的中药，其特征在于:按以下重量份数比制备而成,苏合香11份、苏木11份、安息香8份、蛤蚧5份、阿胶15份、核桃12份、仙茅10份、桑椹子8份、石斛7份、细辛12份。
3.根据权利要求1所述的一种治疗疑病症的中药，其特征在于:按以下重量份数比制备而成,苏合香7份、苏木8份、安息香14份、蛤蚧8份、阿胶11份、核桃9份、仙茅6份、桑椹子10份、石斛13份、细辛7份。
4.根据权利要求1所述的一种治疗疑病症的中药，其特征在于:按以下重量份数比制备而成,苏合香15份、苏木6份、安息香12份、蛤蚧10份、阿胶8份、核桃16份、仙茅8份、桑椹子5份、石斛10份、细辛15份。
5.一种权利要求1所述的治疗疑病性神经症中药的制备方法,其特征在于,制备方法如下:将上述原料晒干、粉碎成细粉,过200目筛,放在铝制的桶里,密封存放10天,取出,阴干3天,装入胶囊。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410576415.3A CN104352801A (zh) | 2014-10-27 | 2014-10-27 | 一种治疗疑病症的中药及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410576415.3A CN104352801A (zh) | 2014-10-27 | 2014-10-27 | 一种治疗疑病症的中药及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104352801A true CN104352801A (zh) | 2015-02-18 |
Family
ID=52520174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410576415.3A Pending CN104352801A (zh) | 2014-10-27 | 2014-10-27 | 一种治疗疑病症的中药及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104352801A (zh) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1245698A (zh) * | 1998-08-24 | 2000-03-01 | 孙宝林 | 一种养血安神冲剂 |
| CN1370528A (zh) * | 2001-02-21 | 2002-09-25 | 陈建操 | 治疗失眠、精神和心理障碍疾病的药物 |
| CN103285251A (zh) * | 2012-02-29 | 2013-09-11 | 黑龙江康元神经专科医院有限责任公司 | 治疗强迫症的中药制剂 |
-
2014
- 2014-10-27 CN CN201410576415.3A patent/CN104352801A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1245698A (zh) * | 1998-08-24 | 2000-03-01 | 孙宝林 | 一种养血安神冲剂 |
| CN1370528A (zh) * | 2001-02-21 | 2002-09-25 | 陈建操 | 治疗失眠、精神和心理障碍疾病的药物 |
| CN103285251A (zh) * | 2012-02-29 | 2013-09-11 | 黑龙江康元神经专科医院有限责任公司 | 治疗强迫症的中药制剂 |
Non-Patent Citations (1)
| Title |
|---|
| 刘恒太，刘庆春: "疑病妄想症", 《山东中医杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102000302B (zh) | 风湿跌打消肿止痛膏及其制备方法 | |
| CN102151325B (zh) | 一种治疗乳腺疾病的中药 | |
| CN101954062B (zh) | 一种治疗慢性咽炎的药物 | |
| CN102920984A (zh) | 治疗风湿关节炎的药物 | |
| CN103394060A (zh) | 一种治疗鼻炎的药物 | |
| CN103721024B (zh) | 一种治疗慢性鼻炎的中药组合物 | |
| CN104383445A (zh) | 一种跌打损伤止痛剂 | |
| CN101721651B (zh) | 一种治疗肩周炎的中药胶囊 | |
| CN106421700A (zh) | 一种活血化瘀的中药酒及其制备与使用方法 | |
| CN102716210A (zh) | 一种治疗风湿骨病的中药及其生产方法 | |
| CN102293961A (zh) | 一种治疗放射性肺炎的中药 | |
| CN101954061B (zh) | 一种治疗慢性喉头炎的药物 | |
| CN104707041B (zh) | 用于痔疮手术后的护理药物 | |
| CN104398949B (zh) | 一种治疗前列腺炎的中药口服液 | |
| CN104352801A (zh) | 一种治疗疑病症的中药及其制备方法 | |
| CN104367939A (zh) | 一种治疗疑病性神经症的中药及其制备方法 | |
| CN104940811A (zh) | 一种治疗跌打损伤及缓解疼痛的外用中药制剂及其制备方法 | |
| CN105055934A (zh) | 一种治疗慢性鼻窦炎的药物及制备方法 | |
| CN104740245A (zh) | 一种治疗鼻窦炎的中药 | |
| CN103768368A (zh) | 一种治疗急性附睾炎的中药组合物 | |
| CN103520415A (zh) | 一种治疗跌打损伤的药物 | |
| CN104435992A (zh) | 一种治疗疑病症的膏药及其制备方法 | |
| CN107456551A (zh) | 一种治疗胃炎的中药 | |
| CN107198740A (zh) | 一种治疗慢性鼻炎的中药组合物 | |
| CN104491703A (zh) | 一种口服治疗膝关节创伤性滑膜炎的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150218 |
|
| WD01 | Invention patent application deemed withdrawn after publication |